{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:37:59Z","timestamp":1790869079777,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.canlet.2009.06.023","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T13:48:25Z","timestamp":1249307305000},"page":"50-56","source":"Crossref","is-referenced-by-count":78,"title":["Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: Their inhibition by curcumin"],"prefix":"10.1016","volume":"288","author":[{"given":"Ji Hye","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang Jin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Jeong","family":"Sul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Sihn","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Kee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Yeun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Ku","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Gyo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.canlet.2009.06.023_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0020-7292(03)90122-6","article-title":"Promising directions for the diagnosis and management of gynecological cancers","volume":"83","author":"Kohn","year":"2003","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.canlet.2009.06.023_bib2","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1006\/gyno.2002.6692","article-title":"Specific keynote: molecular therapeutics in ovarian cancer","volume":"88","author":"Mills","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2009.06.023_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0304-3835(95)03743-G","article-title":"Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis","volume":"91","author":"Gardner","year":"1995","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2009.06.023_bib4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1042\/bst0311209","article-title":"Lysophosphatidic acid: mitogen and motility factor","volume":"31","author":"van Leeuwen","year":"2003","journal-title":"Biochem. Soc. Trans."},{"issue":"Pt 3","key":"10.1016\/j.canlet.2009.06.023_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/bj2910677","article-title":"The bioactive phospholipid lysophosphatidic acid is released from activated platelets","volume":"291","author":"Eichholtz","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2009.06.023_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1023\/A:1008217129273","article-title":"Malignant effusions contain lysophosphatidic acid (LPA)-like activity","volume":"9","author":"Westermann","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2009.06.023_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1388-1981(02)00179-8","article-title":"Lysophosphatidic acid is a bioactive mediator in ovarian cancer","volume":"1582","author":"Fang","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2009.06.023_bib8","doi-asserted-by":"crossref","first-page":"9653","DOI":"10.1074\/jbc.M306662200","article-title":"Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells","volume":"279","author":"Fang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2009.06.023_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/mol.105.017400","article-title":"Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation","volume":"69","author":"Aggarwal","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.canlet.2009.06.023_bib10","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.4049\/jimmunol.171.7.3863","article-title":"Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells","volume":"171","author":"Bharti","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2009.06.023_bib11","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","article-title":"Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]","volume":"270","author":"Singh","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2009.06.023_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00280-007-0674-6","article-title":"Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells","volume":"62","author":"Ji","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2009.06.023_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jcp.10186","article-title":"Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents","volume":"194","author":"Chan","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2009.06.023_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2009.06.023_bib15","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/S0021-9258(18)45911-X","article-title":"Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein","volume":"267","author":"Stracke","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2009.06.023_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/gyno.2000.5931","article-title":"Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells","volume":"79","author":"Huang","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2009.06.023_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/cyto.2002.1022","article-title":"Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas","volume":"17","author":"Savarese","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.canlet.2009.06.023_bib18","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1158\/0008-5472.CAN-03-3959","article-title":"Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility","volume":"64","author":"Silver","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.06.023_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","article-title":"Curcumin inhibits proliferationm, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins","volume":"269","author":"Kunnumakkara","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2009.06.023_bib20","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ejca.2005.05.009","article-title":"Curcumin: the story so far","volume":"41","author":"Sharma","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2009.06.023_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2009.06.023_bib22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bcp.2006.02.009","article-title":"Molecular targets of dietary agents for prevention and therapy of cancer","volume":"71","author":"Aggarwal","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2009.06.023_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ygyno.2004.08.001","article-title":"Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8","volume":"95","author":"So","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2009.06.023_bib24","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1158\/0008-5472.CAN-05-0623","article-title":"Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine","volume":"65","author":"Nilsson","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.06.023_bib25","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.06.023_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1593\/neo.06658","article-title":"SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk","volume":"9","author":"Said","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2009.06.023_bib27","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1158\/1078-0432.CCR-06-0968","article-title":"Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells","volume":"12","author":"Wang","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.06.023_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ijc.20333","article-title":"Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling","volume":"111","author":"Aggarwal","year":"2004","journal-title":"Int. J. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509004467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509004467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T08:25:26Z","timestamp":1633767926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383509004467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0304383509004467"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2009.06.023","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}